Q-Line Biotech Limited

(xix) Total Protein

(xx) Triglycerides

(xxi) Urea UV

(xxii) Uric Acid

iii. Applications filed by the Company for the premises situated at Industrial Property bearing No. C-108, Naraina Industrial Area, Phase - I, New Delhi-110 028, India.

a. The Company has filed an application (Form MD-14) dated September 29, 2025 bearing transaction id no. 2908250065833 for issue of import licence to import medical device from a manufacturer having legal and actual manufacturing site in United States and the medical devices covered in the application for import license are as under:

(i) Microplate Washer (Stat Fax 2600);

(ii) Microplate Reader (Stat Fax 4200); and

(iii) Microstrip Reader (Stat Fax 4700).

b. The Company has filed an application (Form MD-14) dated September 08, 2025 bearing transaction id no. 0709250008697 for issue of import licence to import medical device from a manufacturer having legal and actual manufacturing site in United States and the medical devices covered in the application for import license are as under:

(i) Homocysteine Enzymatic Assay;

(ii) Homocysteine Enzymatic 5 Point Calibrator Set

(iii) Homocysteine Enzymatic Assay Control Set

(iv) Glycated Serum Protein Assay

(v) Glycated Serum Protein Calibrator Set

(vi) Glycated Serum Protein Control Set

(vii) Direct Enzymatic HbA1c Assay

(viii) Direct Enzymatic HbA1c Assay Control Set

(ix) Direct Enzymatic HbA1c Assay Calibrator Set

c. The Company has filed an application (Form MD-14) dated September 26, 2025 bearing transaction id no. 2212230023422 for issue of import licence to import medical device from a manufacturer having legal and actual manufacturing site in United States and the medical devices covered in the application for import license are as under:

(i) Automatic Biochemistry & EIA Analyzer (Model/Catalogue No./Name: ChemWell 2910 - Automatic Biochemistry & EIA Analyzer,)

d. The Company has filed an application (Form MD-14) dated August 28, 2025 bearing transaction id no. 2908250066161 for issue of import licence to import medical device from a manufacturer situated in China and the medical devices covered in the application for import license are as under:

(i) Auto Biochemistry Analyzer (Product Description: Auto-Chemistry Analyzer (Model: CS-T180));

(ii) Auto Biochemistry Analyzer (Product Description: CS-T240PLUS Auto Biochemistry Analyzer);

(iii) Auto Biochemistry Analyzer (Product Description: Auto-Chemistry Analyzer (Model: CS-480));

(iv) Auto Biochemistry Analyzer (Product Description: Auto-Chemistry Analyzer (Model: CS-680));

(v) CS-Alkaline Detergent; and

(vi) CS-Anti-Bacterial Phosphor-Free Detergent.

e. The Company has filed an application (Form MD-14) dated August 22, 2025 bearing transaction id no. 2208250067772 for issue of import licence to import medical device from a manufacturer situated in China and the medical devices covered in the application for import license are as under:

(i) HbA1c Analyser

(ii) Hemoglobin Analyzer

(iii) HbA1c Reagent Kits (HPLC)

(iv) HbA1c Chromatographic Column

(v) β-Thalassemia & HbA1c Assay Column (HPLC)

(vi) HbA1c Calibrator

(vii) HbA1c Control Material

(viii) β-Thalassemia & HbA1c Reagent Kit (HPLC)

(ix) β-Thalassemia & HbA1c Calibrator

(x) β-Thalassemia & HbA1c Control Material

f. The Company has filed an application (Form MD-14) dated September 02, 2025 bearing transaction id no. 2908250065985 for issue of import licence to import medical device from a manufacturer situated in China and the medical devices covered in the application for import license are as under:

(i) Microplate Reader (Product Description: RT-2100C)

308